[1]王 震a,陈林云b,王 琳c,等.结直肠癌患者血清IRF5 和SOCS-3 表达水平对术后肠梗阻的预测价值[J].现代检验医学杂志,2024,39(05):69-74.[doi:10.3969/j.issn.1671-7414.2024.05.013]
　WANG Zhena,CHEN Linyunb,WANG Linc,et al.Predictive Value of Serum IRF5 and SOCS-3 Expression Levels in Colorectal Cancer Patients for Postoperative Intestinal Obstruction[J].Journal of Modern Laboratory Medicine,2024,39(05):69-74.[doi:10.3969/j.issn.1671-7414.2024.05.013]
点击复制

结直肠癌患者血清IRF5 和SOCS-3 表达水平对术后肠梗阻的预测价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年05期
页码:
69-74
栏目:
论著
出版日期:
2024-09-15

文章信息/Info

Title:
Predictive Value of Serum IRF5 and SOCS-3 Expression Levels in Colorectal Cancer Patients for Postoperative Intestinal Obstruction
文章编号:
1671-7414（2024）05-0669-06
作者:
王 震a; 陈林云b; 王 琳c; 刘 峰d
（沧州市人民医院 a. 内镜诊疗中心；b. 神经内科；c. 医学临床检验中心；d. 肛肠外科, 河北沧州 061000）
Author(s):
WANG Zhena; CHEN Linyunb; WANG Linc; LIU Fengd
（a. Endoscopy Diagnosis and Treatment Center; b. Department of Neurology; c. Medical Clinical Laboratory Center; d. Department of Anal and Intestinal Surgery, Cangzhou People’s Hospital,Hebei Cangzhou 061000, China）
关键词:
结直肠癌; 术后肠梗阻; 干扰素调节因子-5; 细胞因子信号转导抑制因子-3
分类号:
R735.3；R730.43
DOI:
10.3969/j.issn.1671-7414.2024.05.013
文献标志码:
A
摘要:
目的 观察结直肠癌患者血清干扰素调节因子-5（interferon regulatory factor-5，IRF5）、细胞因子信号转导抑制因子-3（suppressors of cytokine signaling-3，SOCS-3）水平，并探讨其水平对患者术后肠梗阻发生的预测价值。方法 选取2022 年1 月~2023 年3 月在沧州市人民医院就诊的100 例结直肠癌患者为研究对象，根据患者术后是否发生肠梗阻，将其分为肠梗组（n=14）和对照组（n=86）。酶联免疫吸附（ELISA）法检测术前血清IRF5 和SOCS-3 水平。采用Logistic 回归分析结直肠癌患者术后肠梗阻发生的影响因素。采用受试者工作特征（ROC）曲线分析血清IRF5，SOCS-3 水平对结直肠癌患者术后肠梗阻发生的诊断价值。结果 肠梗组患者血清IRF5 水平（0.68±0.09ng/ml）低于对照组（0.89±0.12ng/ml），血清SOCS-3 水平（97.23±15.94pg/ml）高于对照组(75.03±12.46pg/ml)，差异具有统计学意义（t=6.257，5.937，均P ＜ 0.05）。SOCS-3 是影响结直肠癌患者术后肠梗阻发生的独立危险因素（OR=2.197，95%CI：1.167~4.138，P ＜ 0.05），IRF5 是影响结直肠癌患者术后肠梗阻发生的独立保护因素（OR=0.823，95%CI：0.705~0.961，P ＜ 0.05）。血清IRF5，SOCS-3 以及二者联合诊断结直肠癌患者术后肠梗阻的ROC 曲线下面积（AUC）分别为0.852（95%CI：0.767~0.915），0.817（95%CI：0.727~0.887）和0.953（95%CI：0.891~0.985），二者联合诊断效能高于血清IRF5，SOCS-3 单独检测效能，差异具有统计学意义（Z=1.967，2.034，P=0.049，0.042）。结论 结直肠癌患者血清IRF5 水平降低，SOCS-3 水平升高，且二者对结直肠癌患者发生术后肠梗阻具有一定的预测价值。
Abstract:
Objective To observe serum interferon regulatory factor-5 (IRF5) and suppressors of cytokine signaling-3 (SOCS-3) levels in patients with colorectal cancer, and investigate predictive value of their levels on the occurrence of postoperative intestinal obstruction in patients. Methods A total of 100 colorectal cancer patients who attended the Cangzhou People’s Hospital from January 2022 to March 2023 were selected as the study subjects. According to whether the patient experienced intestinal obstruction after surgery, they were divided into the intestinal obstruction group (n=14) and the control group (n=86). Preoperative serum levels of IRF5 and SOCS-3 were detected by enzyme-linked immunosorbent assay (ELISA). Factors influencing the occurrence of postoperative intestinal obstruction in colorectal cancer patients were analyzed by Logistic regression. Receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum IRF5 and SOCS-3 levels on the occurrence of postoperative intestinal obstruction in colorectal cancer patients. Results Serum IRF5 levels in the intestinal infarction group (0.68±0.09ng/ml) were lower, but serum SOCS-3 levels in the intestinal infarction group (97.23±15.94pg/ml) were higher than in the control group(0.89±0.12ng/ml,75.03±12.46pg/ml), with significant differences (t=6.257, 5.937, all P<0.05). SOCS-3 was an independent risk factor (OR=2.197, 95%CI: 1.167~4.138, P ＜ 0.05), and IRF5 was an independent protective factor (OR=0.823, 95%CI: 0.705~0.961, P ＜ 0.05) affecting the occurrence of postoperative bowel obstruction in patients with colorectal cancer. The areas under the curve (AUC) of serum IRF5, SOCS-3, and the combination of the two for the diagnosis of postoperative intestinal obstruction in colorectal cancer patients were 0.852 (95%CI: 0.767~0.915), 0.817 (95%CI: 0.727~0.887) and 0.953 (95%CI: 0.891~0.985), respectively. The combined diagnostic efficacy of the serum IRF5,SOCS-3 was higher than the efficacy of the test alone, with significant differences (Z=1.967, 2.034, P=0.049,0.042). Conclusion Serum IRF5 levels are reduced, but SOCS-3 levels are increased in patients with colorectal cancer. Both have a predictive value for the development of postoperative bowel obstruction in patients with colorectal cancer.

参考文献/References:

[1] 刘佳奇, 宋健, 张荣琳, 等. Lnc AL137789.1 通过结构化修饰JAK2 蛋白调节结直肠癌细胞增殖与迁移能力[J]. 现代肿瘤医学, 2023, 31(12): 2197-2202. LIU Jiaqi, SONG Jian, ZHANG Ronglin, et al. Lnc AL137789.1 regulates proliferation and migration of colorectal cancer cells by structurally modifying JAK2 protein[J]. Journal of Modern Oncology, 2023, 31(12): 2197-2202.
[2] 易婧雅，曹东林，姚亚超. 结直肠癌根治性手术联合免疫治疗的临床应用研究进展[J]. 中国肿瘤生物治疗杂志, 2023, 30(4): 352-356. YI Jingya，CAO Donglin,YAO Yachao. Research progress in clinical application of radical surgery combined with immunotherapy for colorectal cancer[J]. Chinese Journal of Cancer Biotherapy, 2023, 30(4): 352-356.
[3] 卜宁, 赵敏, 赵莎, 等. 结直肠癌术后肠梗阻的危险因素分析及预测模型建立[J]. 临床麻醉学杂志,2021, 37(7): 677-683. BU Ning, ZHAO Min, ZHAO Sha, et al. Establishment of a nomogram model predicting risk of postoperative ileus after colorectal cancer surgery[J]. Journal of Clinical Anesthesiology, 2021, 37(7): 677-683.
[4] 孙康, 瞿建国, 陈吉祥, 等. 干扰素调节因子5(IRF5)调控小鼠骨髓源性巨噬细胞的极化[J]. 细胞与分子免疫学杂志, 2017, 33(2): 168-173. SUN Kang, QU Jianguo, CHEN Jixiang, et al. Interferon regulatory factor 5 (IRF5) regulates the differentiation of bone marrow-derived macrophages in mice[J]. Chinese Journal of Cellular and Molecular Immunology, 2017, 33(2): 168-173.
[5] VAYRYNEN J P, HARUKI K, LAU M C, et al. The prognostic role of macrophage polarization in the colorectal cancer microenvironment[J]. Cancer Immunology Research, 2021,9(1): 8-19.
[6] DU Jun, SUN Chongqi, LIU Jiaojing, et al. Cytoplasmic localization of IRF5 induces Wnt5a/E-cadherin degradation and promotes gastric cancer cells metastasis[J]. Cancer Gene Therapy, 2023, 30(6): 866-877.
[7] 王梅叶, 冯彩团, 符春梅. 溃疡性结肠炎患者血清I-FABP，miR-223，IRF5 的表达水平及意义[J]. 临床和实验医学杂志, 2022, 21(7): 719-722. WANG Meiye, FENG Caituan, FU Chunmei. Expression level and significance of serum I-FABP, miR-223 and IRF5 in patients with ulcerative colitis[J]. Journal of Clinical and Experimental Medicine, 2022, 21(7): 719-722.
[8] 晏远智, 杨哲, 胡曦丹, 等. SOCS-3 在肝脏疾病中的作用研究进展[J]. 重庆医科大学学报, 2022,47(10): 1154-1158. YAN Yuanzhi, YANG Zhe, HU Xidan, et al. Research progress on the role of SOCS-3 in liver diseases[J]. Journal of Chongqing Medical University, 2022, 47(10): 1154-1158.
[9] 刘荫华, 徐玲. 第七版《AJCC 肿瘤分期手册》结直肠癌内容的更新与解读[J]. 中华胃肠外科杂志,2010, 13(8):629-631. LIU Menghua, XU ling. Update and interpretation of colorectal cancer content in the Seventh Edition of the AJCC Manual of Tumor Staging[J]. Chinese Journal of Gastrointestinal Surgery, 2010, 13(8):629-631.
[10] 王芫, 郭忠英, 周倩, 等. Cdc42EP3 对结直肠癌细胞迁移和侵袭的影响[J]. 中国肿瘤临床, 2023,50(11): 541-549. WANG Yuan, GUO Zhongying, ZHOU Qian, et al. Effects of Cdc42EP3 on migration and invasion of colorectal cancer cells[J]. Chinese Journal of Clinical Oncology, 2023, 50(11): 541-549.
[11] 姜秋利, 鲁华东, 郑景妹等. 结直肠癌组织中RREB1和ANKRD1 的表达与临床病理特征和预后的相关性研究[J]. 现代检验医学杂志,2023,38(1):16-21. JIANG Qiuli, LU Huadong, ZHENG Jingmei, et al. Correlation between the expression of RREB1 and ANKRD1 and clinicopathological features and prognosis in colorectal cancer[J]. Journal of Modern Laboratory Medicine, 2023, 38(1): 16-21.
[12] 曹可, 刁小丽, 于剑锋, 等. 肠梗阻支架置入联合新辅助化疗对完全梗阻性结直肠癌患者手术标本病理特征的影响[J]. 中华胃肠外科杂志, 2022, 25(11):1012-1019. CAO Ke, DIAO Xiaoli, YU Jianfeng, et al. Effect of intestinal obstruction stent combined with neoadjuvant chemotherapy on the pathological characteristics of surgical specimens in patients with complete obstructive colorectal cancer[J]. Chinese Journal of Gastrointestinal Surgery, 2022, 25(11): 1012-1019.
[13] 潘华. 结直肠癌术后肠梗阻的预防及治疗进展[J].中国肛肠病杂志, 2022, 42(2): 77-79. PAN Hua. Progress on preventing and treating postoperative bowel obstruction of colorectal cancer[J]. Chinese Journal of Coloproctology, 2022, 42(2): 77-79.
[14] 陈耀华, 顾佩霞. 干眼患者结膜上皮细胞及泪液中IRF4 和sST2 的表达情况及临床意义[J]. 国际眼科杂志, 2023, 23(6): 904-907. CHEN Yaohua, GU Peixia. Expression and clinical significance of interferon regulatory factor 4 and soluble suppression of tumorigenesis 2 in conjunctival epithelial cells and tears of patients with dry eye[J]. International Eye Science, 2023, 23(6): 904-907.
[15] MOUGIAKAKOS D, BACH C, B?TTCHER M, et al. The IKZF1-IRF4/IRF5 axis controls polarization of myeloma-associated macrophages[J]. Cancer Immunology Research, 2021, 9(3): 265-278.
[16] BI Xiaohui, HAMEED M, MIRANI N, et al. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis[J]. Breast Cancer Research, 2011, 13(6): R111.
[17] 高飞, 贾霖, 韩建军, 等. 鼻咽癌细胞活动性和组织蛋白IRF5 水平的关系研究[C]. 第十届中国肿瘤分子靶向治疗大会. 成都, 2019：165-173. GAO Fei, JIA Lin, HAN Jianjun, et al. Effect of interferon regulatory factor-5 on invasion and migration of nasopharyngeal carcinoma cells[C]. Proceedings of the 10th China Tumor Molecular Targeted Therapy Conference.Chengdu, 2019:165-173.
[18] YAN Jie, PANDEY S P, BARNES B J, et al. T Cellintrinsic IRF5 regulates T cell signaling, migration, and differentiation and promotes intestinal inflammation[J]. Cell Reports, 2020, 31(13): 107820.
[19] KIMURA H, YAMAZAKI T, MIHARA T, et al. Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus[J]. The Journal of Veterinary Medical Science, 2022, 84(4): 610-617.
[20] 赵振中, 谢中华, 汪铁军, 等. 急性胰腺炎患者血清SOCS-3 水平的变化及其临床意义[J]. 中华胰腺病杂志, 2017, 17(5): 294-297. ZHAO Zhenzhong, XIE Zhonghua, WANG Tiejun, et al. Dynamical changes and significance of serum SOCS-3 in patients with acute pancreatitis[J]. Chinese Journal of Pancreatology, 2017, 17(5): 294-297.
[21] NADA H R, RASHED L A, SALMAN O O, et al. Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides[J]. Archives for Dermatological Research, 2023, 315(2): 165-171.
[22] SANAEI M, KAVOOSI F, SAFARZADEH M. Effects of valproic acid on SOCS-1, SOCS-2, SOCS- 3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma[J]. Gastroenterology and Hepatology from Bed to Bench, 2022, 15(1): 39-44.
[23] 虞秀锋, 王启源, 姬文兰, 等. MiR-506-3p/SOCS-3促进BCG 感染巨噬细胞引发的炎症应答反应[J]. 中国人兽共患病学报, 2020, 36(4): 297-302. YU Xiufeng, WANG Qiyuan, JI Wenlan, et al. MiR- 506-3p/SOCS-3 promotes inflammatory responses in BCG-infected macrophages[J]. Chinese Journal of Zoonoses, 2020, 36(4): 297-302.
[24] 朱东东, 孙孟甜. 肠道菌群与溃疡性结肠炎患者血清ET，SOCS-3，TLRs 水平的相关性[J]. 中国微生态学杂志, 2021, 33(4):436-440. ZHU Dongdong, SUN Mengtian. The relationship between intestinal flora and the levels of serum ET, SOCS-3 and TLRs in UC patient[J]. Chinese Journal of Microecology, 2021, 33(4):436-440.

相似文献/References:

[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
　CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[2]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
　ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(05):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[3]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
　SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[4]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
　JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[5]滕祥云,王新梦,刘　维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
　TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(05):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
[6]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
　CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(05):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[7]杨婕琳a,陈文婷b,胡晓利a.结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义[J].现代检验医学杂志,2021,36(06):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
　YANG Jie-lin,CHEN Wen-ting,HU Xiao-li.Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(05):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
[8]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
　MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(05):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
[9]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
　HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(05):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[10]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
　FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(05):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]

备注/Memo

备注/Memo:
基金项目：沧州市重点研发计划自筹项目（编号：222106074）。
作者简介：王震（1991-），男，本科，主治医师，研究方向：结直肠肿瘤，E-mail：ctemzl24@163.com。
通讯作者：刘峰（1989-），男，研究生, 主治医师，研究方向：结直肠肿瘤及肛门病，E-mail：v60koi@163.com。
更新日期/Last Update: 2024-09-15